11. 重症筋無力症 Myasthenia gravis Clinical trials / Disease details

臨床試験数 : 332 / 薬物数 : 234 - (DrugBank : 81) / 標的遺伝子数 : 45 - 標的パスウェイ数 : 127

35 trials found

diseases per page:

Showing 1 to 10 of 35 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT05681715 (ClinicalTrials.gov)	March 9, 2023	4/1/2023	A Phase 3, Open-label, Crossover Study to Evaluate Self-administration of Rozanolixizumabby Study Pa ...	An Open-label, Crossover Study to Evaluate RozanolixizumabSelf-administration by Study Participants ...	Generalized Myasthenia Gravis	Drug: Rozanolixizumab	UCB Biopharma SRL	NULL	Not yet recruiting	18 Years	N/A	All	30	Phase 3	NULL
2	JPRN-jRCT2021200038	09/02/2021	09/02/2021	A study to evaluate rozanolixizumab in study participants with generalized myasthenia gravis	An Open-Label Extension Study to Evaluate Rozanolixizumabin Study Participants With Generalized Myas ...	Generalized Myasthenia Gravis	Rozanolixizumab will be administered by subcutaneous infusion in dosage regimen 1 or 2.	SUGIHARA Kazuhiro	NULL	Recruiting	>= 18age old	Not applicable	Both	18	Phase 3	Belgium;Canada;Czech Republic,;Denmark;France;Georgia;Germany;Hungary;Italy;Poland;Russian Federatio ...
3	NCT04650854 (ClinicalTrials.gov)	February 3, 2021	5/11/2020	A Study to Evaluate Rozanolixizumab in Study Participants With Generalized Myasthenia Gravis	An Open-Label Extension Study to Evaluate Rozanolixizumabin Study Participants With Generalized Myas ...	Generalized Myasthenia Gravis	Drug: Rozanolixizumab	UCB Biopharma SRL	NULL	Active, not recruiting	18 Years	N/A	All	165	Phase 3	United States;Canada;Czechia;Denmark;France;Georgia;Germany;Italy;Japan;Poland;Russian Federation;Se ...
4	EUCTR2020-003230-20-BE (EUCTR)	11/01/2021	07/10/2020	A study to evaluate rozanolixizumab in study participants with generalized myasthenia gravis	An Open-Label Extension Study to Evaluate Rozanolixizumabin Study Participants With Generalized Myas ...	Generalized myasthenia gravis MedDRA version: 21.1;Level: PT;Classification code 10028417;Term: Myas ...	Product Name: Rozanolixizumab Product Code: UCB7665 INN or Proposed INN: ROZANOLIXIZUMAB	UCB Biopharma SRL	NULL	Not Recruiting			Female: yes Male: yes	230	Phase 3	United States;Serbia;Spain;Russian Federation;United Kingdom;Italy;France;Czech Republic;Hungary;Can ...
5	EUCTR2020-003230-20-IT (EUCTR)	15/12/2020	30/08/2021	A study to evaluate rozanolixizumab in study participants with generalized myasthenia gravis	An Open-Label Extension Study to Evaluate Rozanolixizumabin Study Participants With Generalized Myas ...	Generalized myasthenia gravis MedDRA version: 21.1;Level: PT;Classification code 10028417;Term: Myas ...	Product Name: Rozanolixizumab Product Code: [UCB7665] INN or Proposed INN: ROZANOLIXIZUMAB	UCB Biopharma SRL	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	200	Phase 3	Serbia;United States;Czechia;Spain;Russian Federation;United Kingdom;Italy;France;Hungary;Canada;Pol ...
6	EUCTR2020-003230-20-PL (EUCTR)	14/12/2020	30/09/2020	A study to evaluate rozanolixizumab in study participants with generalized myasthenia gravis	An Open-Label Extension Study to Evaluate Rozanolixizumabin Study Participants With Generalized Myas ...	Generalized myasthenia gravis MedDRA version: 21.1;Level: PT;Classification code 10028417;Term: Myas ...	Product Name: Rozanolixizumab Product Code: UCB7665 INN or Proposed INN: ROZANOLIXIZUMAB	UCB Biopharma SRL	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	230	Phase 3	Serbia;United States;Czechia;Spain;Russian Federation;United Kingdom;Italy;France;Hungary;Canada;Pol ...
7	EUCTR2020-003230-20-DE (EUCTR)	02/12/2020	14/09/2020	A study to evaluate rozanolixizumab in study participants with generalized myasthenia gravis	An Open-Label Extension Study to Evaluate Rozanolixizumabin Study Participants With Generalized Myas ...	Generalized myasthenia gravis MedDRA version: 21.1;Level: PT;Classification code 10028417;Term: Myas ...	Product Name: Rozanolixizumab Product Code: UCB7665 INN or Proposed INN: ROZANOLIXIZUMAB	UCB Biopharma SRL	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	200	Phase 3	Serbia;United States;Czechia;Spain;Russian Federation;United Kingdom;Italy;France;Hungary;Canada;Pol ...
8	EUCTR2020-003230-20-HU (EUCTR)	01/12/2020	01/10/2020	A study to evaluate rozanolixizumab in study participants with generalized myasthenia gravis	An Open-Label Extension Study to Evaluate Rozanolixizumabin Study Participants With Generalized Myas ...	Generalized myasthenia gravis MedDRA version: 21.1;Level: PT;Classification code 10028417;Term: Myas ...	Product Name: Rozanolixizumab Product Code: UCB7665 INN or Proposed INN: ROZANOLIXIZUMAB	UCB Biopharma SRL	NULL	Not Recruiting			Female: yes Male: yes	230	Phase 3	United States;Serbia;Spain;Russian Federation;United Kingdom;Italy;France;Hungary;Czech Republic;Can ...
9	EUCTR2020-003230-20-GB (EUCTR)	30/11/2020	02/09/2020	A study to evaluate rozanolixizumab in study participants with generalized myasthenia gravis	An Open-Label Extension Study to Evaluate Rozanolixizumabin Study Participants With Generalized Myas ...	Generalized myasthenia gravis MedDRA version: 21.1;Level: PT;Classification code 10028417;Term: Myas ...	Product Name: Rozanolixizumab Product Code: UCB7665 INN or Proposed INN: ROZANOLIXIZUMAB	UCB Biopharma SRL	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	230	Phase 3	United States;Serbia;Spain;Russian Federation;United Kingdom;Italy;France;Czech Republic;Hungary;Can ...
10	EUCTR2020-003230-20-DK (EUCTR)	17/11/2020	06/10/2020	A study to evaluate rozanolixizumab in study participants with generalized myasthenia gravis	An Open-Label Extension Study to Evaluate Rozanolixizumabin Study Participants With Generalized Myas ...	Generalized myasthenia gravis MedDRA version: 21.1;Level: PT;Classification code 10028417;Term: Myas ...	Product Name: Rozanolixizumab Product Code: UCB7665 INN or Proposed INN: ROZANOLIXIZUMAB	UCB Biopharma SRL	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	200	Phase 3	Serbia;United States;Czechia;Spain;Russian Federation;United Kingdom;Italy;France;Hungary;Canada;Pol ...

First Previous1 2 3 4Next Last